IFNG and graft versus host disease: The patient exhibited a 50% decrease in the production of the pro-inflammatory cytokines IL-1β, TNF-α, and IFN-γ and concomitant a reduction of diarrhea and cutaneous and mucosal GvHD, which remained stable for more than 4 months post MSC-EV treatment (103).